BioNTech Comirnaty COVID-19 Vaccine from United States
BioNTech Comirnaty is an mRNA-based COVID-19 vaccine that induces spike protein production to trigger an immune response. It is packaged in multi-dose vials for retail sale, fitting the definition of an immunological product in measured doses.
Duty Rate — United States → Canada
0%
Import Tips
• Secure a Health Canada import authorization for the vaccine
• Keep chain-of-custody records for cold-chain compliance
• Declare the product's mRNA technology and retail packaging to CBSA